---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-017691"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2025-10-10T23:59:59+00:00"
generated_at: "2026-05-17T04:04:59.434989+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# enVVeno Medical receives Nasdaq bid-price deficiency notice; cure period to April 2026

## Summary
- Nasdaq notified enVVeno on Oct 7, 2025 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until April 6, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive trading days.
- If unmet, may seek 180-day extension by meeting other listing standards and committing to reverse stock split.
- No immediate effect on listing; stock remains on Nasdaq Capital Market pending cure or appeal.

## SEC filing metadata
- accession: 0001493152-25-017691
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2025-10-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/0001493152-25-017691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-017691
- JSON: https://secwatch.observer/filing/0001493152-25-017691.json
- Plain text: https://secwatch.observer/filing/0001493152-25-017691.txt

## Key facts
- Listing & Compliance Notices
  enVVeno Medical Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: October 7, 2025, enVVeno Medical Corporation (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Rule 5550(a)(2) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/0001493152-25-017691-index.htm
- Listing & Compliance Notices
  enVVeno Medical Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: October 7, 2025, enVVeno Medical Corporation (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Rule 5550(a)(2) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/0001493152-25-017691-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.